BPCR.L Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (23 Apr 2024 @ 11:29):

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its assets are secured by royalties or other cash flows derived from the sales of approved life sciences products...

Stats
Today's Volume	2.13M
Average Volume	1.74M
Market Cap	10.80M
EPS	$0 ( 2024-03-27 )
Last Dividend	$0.0175 ( 2023-08-17 )
Next Dividend	$0 ( N/A )
P/E	10.95
ATR14	$0.00100 (0.11%)

Volume Correlation

Long: -0.09 (neutral)

Short: 1.00 (very strong)

Signal:(47.826) Expect same movement, but be aware

BioPharma Credit PLC Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

BioPharma Credit PLC Correlation - Currency/Commodity

0.00
( neutral )

-0.07
( neutral )

BioPharma Credit PLC Financials

Annual	2023
Revenue:	$110.49M
Gross Profit:	$110.49M (100.00 %)
EPS:	$0

Q2	2023
Revenue:	$39.26M
Gross Profit:	$39.26M (100.00 %)
EPS:	$0.0269

Q1	2023
Revenue:	$39.26M
Gross Profit:	$39.26M (100.00 %)
EPS:	$0.0269

Q4	2022
Revenue:	$71.11M
Gross Profit:	$71.11M (100.00 %)
EPS:	$0.0421

Financial Reports:

No articles found.

BioPharma Credit PLC Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.0175 (N/A)	$0.0450 (N/A)	$0.0158 (N/A)	$0.0175 (N/A)	$0.0175 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

BioPharma Credit PLC Dividend Information - Dividend Knight

Dividend Sustainability Score: 8.03 - good (80.34%) | Divividend Growth Potential Score: 4.76 - Stable (4.79%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.0100	2017-09-28
Last Dividend	$0.0175	2023-08-17
Next Dividend	$0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	25	--
Total Paid Out	$0.385	--
Avg. Dividend % Per Year	1.46%	--
Score	4.25	--
Div. Sustainability Score	8.03
Div.Growth Potential Score	4.76
Div. Directional Score	6.40	--

Next Divdend (Est)
(2024-07-01)

$0.0175 Estimate 21.90 %

Dividend Stability

0.58 Average

Dividend Score

4.25

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
2017	$0.0200	0.02%
2018	$0.0594	0.06%
2019	$0.0543	0.05%
2020	$0.0479	0.05%
2021	$0.0554	0.06%
2022	$0.0975	0.10%
2023	$0.0508	5.35%
2024	$0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for LSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
PRV.L	Dividend Knight	2023-07-20	Semi-Annually	32	0.57%
GHH.L	Dividend Knight	2023-06-22	Annually	27	0.91%
ANCR.L	Dividend Knight	2023-06-15	Annually	17	0.88%
TMG.L	Dividend Junior	2023-07-13	Annually	18	2.26%
LWI.L	Dividend King	2023-06-29	Quarterly	53	2.58%
CRH.L	Dividend Knight	2023-10-19	Semi-Annually	31	2.09%
RNWH.L	Dividend Knight	2023-06-08	Annually	30	1.48%
HL.L	Dividend Knight	2023-11-16	Semi-Annually	17	1.28%
BBGI.L	Dividend Knight	2023-09-07	Semi-Annually	13	2.94%
UU.L	Dividend Knight	2023-06-22	Semi-Annually	32	2.55%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.855	1.500	10.00	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0960	1.200	6.80	8.16	[0 - 0.3]
returnOnEquityTTM	0.0962	1.500	-0.0426	-0.0639	[0.1 - 1]
payoutRatioTTM	0.547	-1.000	4.53	-4.53	[0 - 1]
currentRatioTTM	21.75	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	21.72	0.800	10.00	8.00	[0.8 - 2.5]
cashRatioTTM	13.74	1.500	10.00	10.00	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	0	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	0.0845	2.00	9.97	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.0845	2.00	9.96	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	1.000	1.000	10.00	10.00	[0.2 - 0.8]
operatingProfitMarginTTM	0.855	1.000	10.00	10.00	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0.112	0.800	-2.58	-2.07	[0.5 - 2]
Total Score				8.03

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	8.99	1.000	9.19	0	[1 - 100]
returnOnEquityTTM	0.0962	2.50	-0.0274	-0.0639	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.0845	2.00	9.97	10.00	[0 - 30]
dividendYielPercentageTTM	13.68	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.0845	2.00	9.97	10.00	[0 - 30]
payoutRatioTTM	0.547	1.500	4.53	-4.53	[0 - 1]
pegRatioTTM	-0.332	1.500	-5.55	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.743	1.000	10.00	0	[0.1 - 0.5]
Total Score				4.76

BioPharma Credit PLC